What effect would the shorts have on NWBO at this stage of the game? Is LP worried they will influence the FDA decision? I can understand the reason to be protective during the trial when you are trying to raise funds but at this point the game is over. Data is locked, needs compiling and shipped to FDA.
Either way I placed my wager. I think UK approval comes first and FDA will have no choice but to approve. The efficacy of the Keytruda combo should gain quick attention. And with some proper PR DCVAX-Direct will intrigue as we begin phase 2. NWBO will eventually be the belle of the ball. Will keep adding while we wait. Anxious to see how market reacts and if in fact we see a squeeze. Also wish I could get my hands on some calls options
Market Data 
Markets 
AI
